Calculates REVEAL 2.0 risk score for pulmonary arterial hypertension using 12 clinical parameters including 6MWT, NYHA class, RHC measurements, NT-proBNP, and echocardiographic parameters to guide treatment escalation.
BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).
BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.
Calculates REVEAL 2.0 risk score for pulmonary arterial hypertension using 12 clinical parameters including 6MWT, NYHA class, RHC measurements, NT-proBNP, and echocardiographic parameters to guide treatment escalation
Each component has a specific meaning:
Note: Interpret the pah risk stratification result against the clinical thresholds and context described above.
Enter the 12 clinical parameters including 6MWT, NYHA class, RHC measurements, NT-proBNP, echocardiographic parameters for the patient or scenario you are assessing. Calculates REVEAL 2.0 risk score for pulmonary arterial hypertension using 12 clinical parameters including 6MWT, NYHA class, RHC measurements, NT-proBNP, and echocardiographic parameters to guide treatment escalation. Use the pah risk stratification result to inform your clinical assessment.